Medicover Genetics

Medicover Genetics is a strategic business area integrating the Diagnostic Services division’s extensive genetic testing capabilities. It was developed as a greenfield approach including the acquisitions of several key institutions in Germany to build a strong foundation for our ambition to become a market leader in genetics. Our purpose is to empower people to use comprehensive and meaningful genetic tests at the forefront of their diagnostic journey, fuelled by our vision to place genetics at the core of medical decisions. We want to achieve this by leveraging advancements in genomics to develop relevant diagnostic solutions, supported by professional medical interpretation, to improve people’s health and well-being.

What We Do

Medicover Genetics offers an extensive genetic testing portfolio to help health care professionals identify the most appropriate genetic test for their patients. Too often is genetic testing considered only very late during a diagnostic journey of a patient, and our mission is to shorten this journey by creating opportunities for the physicians and patients to find the right information about genetic disorders, genetic testing and associated genes. Additionally, we accompany both, the physician and the patient, throughout the genetic testing journey, by offering medical counselling with ordered tests. We believe this is very important for the patient to understand the results of the test, and is also useful for the physician to discuss therapeutic options, preventative measures and monitoring procedures.

Our website, www.medicover-genetics.com, has been developed such that our visitors can find information on basic genetics and genetic testing, and a list of tests that have been categorized into different areas, including rare hereditary diseases, reproductive health, oncology and whole exome sequencing. 

How we do it

Spanning cytogenetic analyses, molecular pathology solutions, the latest in Next Generation Sequencing (NGS) technology and microbiome sequencing, Medicover Genetics offers a complete in-house and tailormade portfolio produced in our laboratories in Germany and offered internationally. Medicover is the sole testing site in Europe for Bionano’s Saphyr® technology. The third-generation optical mapping solution aims to provide the missing information in genome research with rapid, high-throughput, long-range genome mapping and unmatched structural variation discovery capabilities. If proven successful, this technology will allow Medicover to resolve large-scale structural variations currently missed by NGS.

To operate smoothly on a global scale, while expanding the sample volume, we implemented an end-to-end clinical suite for a more robust diagnostics pipeline and a solution that could accommodate different geographic locations with one local installation. This allows us to make NGS testing and variant discovery efficient, scalable and accessible by converting NGS data into customized clinical reports in a timely manner.

Why Us

We are a network of laboratories and medical institutions that date back to 1998 and given our expertise with genetic testing for over 2 decades, we have become leaders amongst health care professionals, especially in Germany. Our clinical team is comprised of scientists, physicians and medical geneticists, several with >20 years of experience in genetic testing, assuring that we are offering meaningful and comprehensive genetic tests and accurate interpretation of sequencing results. We use up-to-date diagnostic algorithms and gene panels based on current scientific literature and international guidelines. We are constantly updating our sequencing facilities so that we are using the latest technology and laboratory methods which allows for short turnaround times. We are assessed by several certified bodies, including EFI, DIN EN ISO 9001, DIN EN ISO15189 accreditation for medical laboratories, DIN EN ISO/IEC 17025 accreditation for testing and calibration laboratories and a generally valid GMP (Good Medical Practice) certificate. We take data privacy very seriously and do not use genetic data for any purpose besides what is stated in the informed consent form signed by the patient and physician. 

Our Portfolio

Our test portfolio has been compiled to offer meaningful predictive and diagnostic tests that range from hotspot testing (single variant tests), to whole exome sequencing. Our portfolio can be broken down into four main categories; oncology, rare disease panels, reproductive health and whole exome sequencing. In oncology, we offer hereditary and somatic tumor cancer panels and our rare disease panels are categorized into 16 categories, each with 10 or more subpanels that have been compiled for specific indications. Our reproductive health portfolio accompanies a person throughout their reproductive lifetime by offering fertility panels, carrier testing and non-invasive prenatal tests for pregnant women. 

For a full list of tests and scientific information on syndromes and panels offered, please visit our website: www.medicover-genetics.com